Downstaging of hepatocellular carcinoma with radiofrequency ablation on the Hungarian liver transplantation waiting list - Early results and learned lessons

Interventional Medicine and Applied Science

Volumn 1, Issue 1, 2009, Pages 41-45

  Hartmann, E ^a   Nemeth A ^a   Juharosi, Gy ^a   Lénárd, Zs ^a   Deak P ^a   Kozma, V ^a   Nagy, P ^a   Gerlei, Zs ^a   Fehervari I ^a   Nemes, B ^a   Gorog D ^a   Fazakas, J ^a   Kobori L ^a   Doros, A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

cirrhosis; hepatocellular carcinoma; liver transplantation; radiofrequency ablation; tumour ablation therapy; waiting list

Indexed keywords

EID: 79957622654     PISSN: 20611617     EISSN: 20615094     Source Type: Journal    
DOI: 10.1556/IMAS.1.2009.1.6     Document Type: Article

References (20)

1. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. The Lancet 362, 1907-1917 (2003)
2. Ishizaki Y, Kawasaki S: The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 43, 18-26 (2008)
3. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW: Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41(5), 1130-1137 (2005)
4. Johnson EW, Holck PS, Levy AE, Yeh MM, Yeung RS: The Role of Tumor Ablation in Bridging Patients to Liver Transplantation. Arch Surg. 139, 825-830 (2004)
5. Galandi D, Antes G: Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma (Cochrane Review). The Cochrane Library, Issue 2 (2004)
6. Ebied OM, Federle MP, Carr BI, Pealer KM, Li W, Amesur N, Zajko A: Evaluation of Responses to Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma. Cancer 97, 1042-1050 (2003)
7. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C: Small Hepatocellular Carcinoma in Cirrhosis: Randomized Comparison of Radio-frequency Thermal Ablation versus Percutaneous Ethanol Injection. Radiology 228, 235-240 (2003)
8. Nemes B, Polak W, Ther G, Hendriks H, Kóbori L, Porte RJ, Sárváry E, de Jong KP, Doros A, Gerlei Zs, van der Berg AP, Fehérvári I, Görög D, Peeters PM, Járay J, Slooff MJ: Analysis of Differences in Outcome of Two European Liver Transplant Centers. Transplant International 19, 372-380 (2006)
9. Bánsághi Z: A rádiófrekvenciás ablatio helye a malignus daganatok kezelésében. Lehet ségek és korlátok. Magyar Sebészet 61(2), 59-64 (2008)
10. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334, 693-699 (1996)
11. Lubienski A: Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 80 (1 Suppl), S113-S119 (2005)
12. Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Long term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235, 373-382 (2002)
13. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F, Sommacale D, Dondero F, Lesurtel M, Sauvanet A, Farges O, Kianmanesh R Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238, 885-893 (2003)
14. Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, Gores G: Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transpl 10; 449-455 (2004)
15. Hayashi PH, Ludkowski M, Forman LM, Osgood M, Johnson S, Kugelmas M, Trotter JF, Bak T, Wachs M, Kam I, Durham J, Everson GT: Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 4, 782-787 (2004)
16. Omata M, Tateishi R, Yoshida H, Shiina S: Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 127, S159-S166 (2004)
17. Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, della Pina C, Bargellini I, Cioni D, Oliveri F, de Simone P, Bartolozzi C, Brunetto M, Filippon F: Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study. Journal of Hepatology 49, 217-222 (2008)
18. Yamashiki N, Tateishi R, Yoshida H, Shiina S, Teratani T, Sato S, Mine N, Kondo Y, Kawabe T, Omata M: Ablation Therapy in Containing Extension of Hepatocellular Carcinoma: A Simulative Analysis of Dropout From the Waiting List for Liver Transplantation. Liver Transplantation 11, 508-514 (2005)
19. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL: Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transplantation 11, 1117-1126 (2005)
20. Kim RD, Reed AI, Fujita S, Foley DP, Mekeel KL, Hemming AW: Consensus and Controversy in the Management of Hepatocellular Carcinoma. J Am Coll Surg 205, 108-123 (2007)